John M. Mandrola, MD

Is AFib ablation the fifth pillar in heart failure care? CASTLE-HTx

Author:: John M. Mandrola, MD; Christian Sohns, MD, PhD; And Philipp Sommer, MD

Publish date: September 12, 2023

Catheter ablation was superior to medical therapy alone in terms a composite endpoint of death from any cause or left...

Publish date: September 5, 2023

This is the kind of science that medicine should celebrate. There were no soft endpoints, financial conflicts, or spin.

Publish date: August 10, 2023

Though there is plausibility and multiple reasons to infer causality of marine omega-3s in increasing AFib risk, the effect size remains unknown...

Publish date: March 10, 2023

New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.

Publish date: May 12, 2022

Ablation has hogged the electrophysiology spotlight recently, but three presentations at the 2022 Heart Rhythm Society meeting put cardiac pacing...

Publish date: February 17, 2022

How many nonsignificant trials do we need before researchers stop studying vitamin D, doctors stop (routinely) measuring levels, and patients stop...

Publish date: January 25, 2022

We shouldn’t be worried about non-MD clinicians, said Dr. John Mandrola, but there are ways to increase confidence in NP and PA care.